No clinical benefit in mortality associated with hydroxychloroquine treatment in patients with COVID-19

por Sands, Kenneth, Wenzel, Richard, McLean, Laura, Korwek, Kimberly, Roach, Jonathon, Miller, Karla, Poland, Russell E., Burgess, L. Hayley, Jackson, Edmund, Perlin, Jonathan B.
Publicado 2021

Patient characteristics and admitting vital signs associated with coronavirus disease 2019 (COVID-19)–related mortality among patients admitted with noncritical illness

por Sands, Kenneth E., Wenzel, Richard P., McLean, Laura E., Korwek, Kimberly M., Roach, Jonathon D., Miller, Karla M., Poland, Russell E., Burgess, L. Hayley, Jackson, Edmund S., Perlin, Jonathan B.
Publicado 2020

Changes in hospitalized coronavirus disease 2019 (COVID-19) patient characteristics and resource use in a system of community hospitals in the United States

por Sands, Kenneth E., Wenzel, Richard P., McLean, Laura E., Korwek, Kimberly M., Roach, Jonathon D., Poland, Russell E., Miller, Karla M., Burgess, L. Hayley, Jackson, Edmund S., Perlin, Jonathan B.
Publicado 2020

Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson’s Disease

por Hacker, Mallory L., Currie, Amanda D., Molinari, Anna L., Turchan, Maxim, Millan, Sarah M., Heusinkveld, Lauren E., Roach, Jonathon, Konrad, Peter E., Davis, Thomas L., Neimat, Joseph S., Phibbs, Fenna T., Hedera, Peter, Byrne, Daniel W., Charles, David
Publicado 2016